Dr Agarwals Eye Hospital balance sheet

As of Mar 2026

Total assets: ₹766cr+25.0% on Mar 2025
Shareholders' equity: ₹346cr+65.2% on Mar 2025
Total debt: ₹81.8cr−15.1% on Mar 2025
Cash and investments: ₹95.7cr+280.3% on Mar 2025

₹ crore except per share

Tap a line for its trend	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Current assets
Non-current assets					FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	375	365	315	259
	197	128	97.4	62.2
	5.7	5.7	0.2	0.2
	22.1	22.4	0.6	1.0
	11.4	10.0	8.5	7.1
	11.4	—	8.5	7.1
	9.7	9.7	10.0	10.1
	9.0	14.3	4.3	3.6
	630	557	436	343
	14.1	13.4	9.8	6.0
	89.1	14.0	—	—
	18.7	14.0	12.9	10.1
	6.6	11.2	32.9	27.4
	0.1	1.0	0.9	0.7
	3.9	2.2	2.0	2.1
	118	—	48.6	40.3
	4.1	1.6	1.5	0.2
	137	55.9	59.8	46.5
	766	613	496	390
Equity
	4.8	4.7	4.7	4.7
	341	205	152	109
	346	210	157	113
	346	210	157	113
Liabilities
	67.1	81.8	44.5	35.8
	2.3	2.3	2.4	1.6
	10.6	8.8	7.4	6.2
	309	317	258	222
	14.7	14.6	6.8	8.1
	—	—	—	26.7
	34.0	22.3	20.3	4.5
	3.0	1.4	1.3	1.0
	12.3	0.0	10.0	—
	5.0	5.5	5.2	4.1
	111	87.0	80.8	55.1
	420	404	339	277
	766	613	496	390

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

alphave

DRAGARWQ₹5,112.00

Dr Agarwals Eye Hospital Limited

· Pharma & Health

₹ CrorePeersKMCSHIL KOVAI LOTUSEYE GPTHEALTH GKSL SHALBY INDRAMEDCO ARTEMISMEDMcap ₹2,437 Cr

View

In ₹ Crore except Per Share As of	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026
Non-current Assets
+ Property, Plant & Equipment	259.2	314.8	365.1	374.8
+ Capital Work-in-Progress	62.2	97.4	128.0	197.3
+ Goodwill	0.2	0.2	5.7	5.7
+ Other Intangibles	1.0	0.6	22.4	22.1
+ Other Non-current Financial Assets	7.1	8.5	10.0	11.4
Non-current Financial Assets	7.1	8.5	—	11.4
+ Deferred Tax Assets	10.1	10.0	9.7	9.7
+ Other Non-current Assets	3.6	4.3	14.3	9.0
Total Non-current Assets	343.4	435.9	557.4	629.9
Current Assets
+ Inventories	6.0	9.8	13.4	14.1
+ Current Investments	—	—	14.0	89.1
+ Trade Receivables	10.1	12.9	14.0	18.7
+ Cash & Cash Equivalents	27.4	32.9	11.2	6.6
+ Other Bank Balances	0.7	0.9	1.0	0.1
+ Other Current Financial Assets	2.1	2.0	2.2	3.9
Current Financial Assets	40.3	48.6	—	118.4
+ Other Current Assets	0.2	1.5	1.6	4.1
Total Current Assets	46.5	59.8	55.9	136.5
Total Assets	389.9	495.8	613.3	766.5
Equity
+ Equity Share Capital	4.7	4.7	4.7	4.8
+ Other Equity / Reserves	108.6	152.5	204.9	341.5
Equity — Owners of Parent	113.3	157.2	209.6	346.3
Total Equity	113.3	157.2	209.6	346.3
Liabilities
+ Borrowings — Non-current	35.8	44.5	81.8	67.1
+ Other Non-current Financial Liab	1.6	2.4	2.3	2.3
+ Provisions — Non-current	6.2	7.4	8.8	10.6
Non-current Liabilities	221.5	257.8	316.7	308.8
+ Borrowings — Current	8.1	6.8	14.6	14.7
+ Trade Payables	26.7	—	—	—
+ Other Current Financial Liab	4.5	20.3	22.3	34.0
+ Provisions — Current	1.0	1.3	1.4	3.0
+ Current Tax Liabilities	—	10.0	0.0	12.3
+ Other Current Liabilities	4.1	5.2	5.5	5.0
Current Liabilities	55.1	80.8	87.0	111.4
Total Liabilities	276.6	338.6	403.7	420.2
Total Equity & Liabilities	389.9	495.8	613.3	766.5

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 85%.